Connectez-vous pour accéder aux recommandations de stratégie gagnante.
Se connecterPassez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.
Se connecterL'analyse des exigences par l'IA n'est pas encore disponible pour cet appel d'offres.
Les exigences seront générées automatiquement lorsque les documents de l'appel d'offres seront traités.
9 documents disponibles avec des résumés IA
This document contains the tender conditions for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kauno Klinikos.
This document contains the special conditions for the purchase and sale agreement of the medicinal product Polatuzumab vedotin.
This document is the European Single Procurement Document (ESPD) Annex 3, used for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kaunas Clinics.
This document contains a tender notice for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kauno Klinikos.
This document contains the general terms and conditions for the purchase and sale of goods, defining key terms and outlining the interpretation and hierarchy of contractual documents for the procurement of the medication Polatuzumab vedotin.
This document contains the technical specification for the drug Polatuzumab vedotin, outlining requirements for its registration, labeling, and shelf life.
This document contains a price list for the medication Polatuzumab vedotin, including item number, nomenclature, unit of measure, quantity, and pricing details.
This document contains the complete tender structure for the Medikamentas Polatuzumab vedotin procurement, requiring a file submission.
This document contains a European Single Procurement Document (ESPD) request related to the procurement of the drug Polatuzumab vedotin, specifically addressing exclusion criteria regarding participation in criminal organizations.
Inscrivez-vous pour consulter les résumés et l'analyse des documents
This tender for Polatuzumab vedotin is generally well-structured with clear documentation, but lacks specific details on evaluation criteria and financing, impacting practicality and completeness.
The tender adheres to EU procurement directives (Code: 2014/24/ES) and uses standard forms like the ESPD. The CPV code is appropriate. No disputes are indicated. Deadlines appear reasonable for an open procedure, though the submission deadline is relatively short. The lack of explicit mention of regulatory compliance beyond standard EU directives is a minor point.
The title, description, and CPV code are clear. Key documents like technical specifications and contract terms are provided. However, the absence of specified evaluation criteria leaves a significant gap in understanding how bids will be assessed.
Most basic information is present, including the organization, reference, and contract duration. However, the estimated value is not disclosed, which is a significant omission. While many documents are attached, the lack of explicit financial information and detailed requirements in some sections reduces overall completeness.
The tender is an open procedure, suggesting broad access. Standard EU procurement documents are used, promoting fairness. There are no immediately apparent requirements tailored to specific companies. The value is not disclosed, which could be a concern for some bidders, but the overall structure is objective.
The tender is marked as 'E-Procurement', suggesting electronic submission is possible, but this is not explicitly detailed. The contract start date is not specified. The financing source is indicated as 'EU Funded', but specific financing details or budget allocation are missing. The lack of disclosed value and evaluation criteria also impacts practicality.
Key fields like title, reference, organization, and deadlines are populated. The status is 'active', and there are no reported suspensions or disputes. Dates are logical, with an opening date shortly after the submission deadline. The CPV code and NUTS code are present.
The tender is marked as 'EU Funded', which implies adherence to certain EU standards. However, there are no explicit mentions of green procurement, social aspects, or innovation within the provided information, suggesting these are not primary considerations.
Inscrivez-vous pour consulter les exigences et l'analyse complètes
Aucune carte de crédit requise • Configuration en 2 minutes
Nos experts en marchés publics préparent tout. Solution éprouvée — vous relisez, validez et soumettez.
Bonjour ! Je suis votre assistant IA pour cet appel d'offres. Je peux vous aider à comprendre les exigences, les délais, les critères d'admissibilité et vous fournir des informations stratégiques.
Aucune carte de crédit requise